title: The association between C-reactive protein on admission and mortality in patients with acute myocardial infarction.
abstract: OBJECTIVE
  In patients presenting with acute myocardial infarction the pathophysiologic and prognostic value of serum C-reactive protein is not well defined. This study assessed the association between serum C-reactive protein levels on admission and mortality in patients admitted because of acute myocardial infarction.
  
  
  METHODS
  Retrospective cohort study.
  
  
  METHODS
  Tertiary care centre.
  
  
  METHODS
  A total of 729 patients with acute myocardial infarction admitted within a period of 3 years.
  
  
  METHODS
  C-reactive protein levels on admission, cardiovascular risk factors and survival within the observational period.
  
  
  RESULTS
  Within the 3-year observational period, 118 patients died of a cardiovascular cause. With increasing serum C-reactive protein levels (<0.5, 0.5 to <2, 2 to <5, 5-10 and >10 mg dL-1) mortality also increased (14%, 19%, 20%, 39% and 28%, respectively). When controlling for the confounding effect of age, thrombolytic treatment, the time interval between onset of pain and admission, smoking, diabetes mellitus, hypercholesterolemia, hypertension, and elevated creatine kinase on admission in a multivariate Cox regression model, there was only a weak and nonsignificant association between increased serum C-reactive protein and the risk of death.
  
  
  CONCLUSIONS
  Patients with elevated concentrations of serum C-reactive protein admitted to the hospital because of acute myocardial infarction are at an increased risk of dying. This association is however, largely explained by other baseline variables, in particular by an estimate of the duration of myocardial ischaemia. If C-reactive protein measured by means of an ultra-sensitive assay is more suitable for risk stratification of unselected patients with acute myocardial infarction, needs further study.
authors.affiliation: Department of Internal Medicine II, Division of Cardiology, Vienna General Hospital, University of Vienna, Austria.
authors.forename: M
authors.initials: M
authors.lastname: Nikfardjam
authors.forename: M
authors.initials: M
authors.lastname: Müllner
authors.forename: W
authors.initials: W
authors.lastname: Schreiber
authors.forename: E
authors.initials: E
authors.lastname: Oschatz
authors.forename: M
authors.initials: M
authors.lastname: Exner
authors.forename: H
authors.initials: H
authors.lastname: Domanovits
authors.forename: A N
authors.initials: AN
authors.lastname: Laggner
authors.forename: K
authors.initials: K
authors.lastname: Huber
mesh_terms: D000368:Aged; D002097:C-Reactive Protein / Q000378:metabolism*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood* / Q000401:mortality*; D010343:Patient Admission; D012189:Retrospective Studies; D012307:Risk Factors; D016019:Survival Analysis
chemical_list: D002097:C-Reactive Protein